the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Between medicine and glamour

ADRINA Kamaruddin, widely known as Adrina Kamjo, is not your ordinary 25-year-old. She is one of the few souls brave enough to juggle a demanding career in medicine with the spot lit world of modelling and acting.

Born and raised in Kota Baru, Kelantan, she ventured to Sarawak for her Foundation in Life Science at Universiti Malaysia Sarawak and later pursued a degree in Bachelor of Medicine and Bachelor of Surgery at the University of Cyberjaya. Reflecting on her formative years, Adrina shared: “The exposure I had since young has honed my interpersonal skills and equipped me with a diverse set of tools to thrive in my professional career.”

Cultural immersion

During her student exchange programmes in Singapore and Japan, Adrina immersed herself in diverse cultures, shaping her worldview.

“In Japan, I was captivated by the strong emphasis on moral values. In Singapore, I adapted quickly to new environments and developed creative thinking skills.”

These experiences would later influence her approach to patient care and medical ethics.

Medicine and passion

Balancing a burgeoning career in medicine with her passion for acting and modelling is no small feat for Adrina. She confesses that she is not quite sure how she is managing but she is somehow able the fine balancing act.

She emphasised setting priorities and maintaining a non-negotiable commitment to medicine.

“I remembered a time when I wanted to audition for Dewi Remaja but was not supported by my parents. Now that I have graduated, nothing is holding me back,” said Adrina as she reminisced about her early aspirations.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings